Heavy-Ion Cancer Therapy Report Highlights China's Hospital Quality Congress

China's Heavy-Ion Cancer Therapy Clinical Report Draws High Attention at National Hospital Quality Congress

--The precise heavy ion technology provides a new pathway for value-based standardized tumor treatment

On November 9, the 2024 China Hospital Quality Conference was held in Hangzhou, Zhejiang Province. The event attracted participation from numerous academicians of the Chinese Academy of Sciences and Chinese Academy of Engineering, renowned experts and scholars, as well as senior hospital administrators. Themed "Advanced Concepts and Practical Experiences in Hospital Reform and Development in the New Era," the conference aimed to promote continuous progress and innovation in China's healthcare sector.

At the session themed "Clinical Value-Oriented Standardized Management of Tumors," Professor Ye Yancheng, a State Council Special Allowance recipient, leading talent of Gansu Province, and President of our hospital, delivered an academic report titled "The Development Path of China's First Heavy Ion Tumor Treatment System." His presentation attracted extensive attention and sparked lively discussions among the conference participants.

Professor Ye Yancheng pointed out in his report that in recent years, Wuwei Heavy Ion Center has been committed to improving medical quality and the standardized management of tumor treatment, comprehensively implementing the "biological, social, and psychological" medical model to provide comprehensive, whole-life-cycle health management. The center has developed the "Two Cycles and Three Multiples" quality management tool for heavy ion therapy, established and improved the "Carbon Ion Therapy System Usage Quality Management System" and the "Carbon Ion Therapy System Operation and Maintenance Quality Management System." Collaborating with experts from Peking University Third Hospital, the center compiled SOP standardized operating procedures for carbon ion therapy systems covering clinical practice, technical applications, physics, and follow-up care. Meanwhile, the center strictly adheres to standards such as the "Standard Operating Procedures for Carbon Ion Radiotherapy" and the "Post-Market Surveillance Plan for Carbon Ion Therapy Systems" to ensure the safety and efficacy of the treatment process.

It is reported that since its clinical operation, the Wuwei Heavy Ion Center has successfully treated nearly 1,600 patients. These patients come from all provinces, municipalities and autonomous regions across China, including Taiwan, Hong Kong and Macau, as well as from countries such as Belgium and Australia. The treated patients have shown remarkable therapeutic efficacy and excellent tolerance.

The attending delegates unanimously agreed that Professor Ye Yancheng's report not only showcased the latest advancements and achievements in China's heavy ion tumor therapy technology, but also brought new insights and perspectives to the global oncology field. They spoke highly of the innovative practices in quality management demonstrated by Wuwei Heavy Ion Center, noting that these experiences hold significant value for advancing global healthcare quality improvement.

The recognition of Wuwei Heavy Ion Center's comprehensive, whole-life-cycle tumor patient health management by the attendees is a testament to China's medical technological prowess. Moving forward, Wuwei Heavy Ion Center will continue to uphold the principles of innovation, quality, and service, striving to enhance treatment standards and management capabilities to provide global cancer patients with even more exceptional and efficient medical services.